BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Glaucoma Foundation - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Glaucoma Foundation
X-ORIGINAL-URL:https://glaucomafoundation.org
X-WR-CALDESC:Events for The Glaucoma Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241113T170000
DTEND;TZID=America/New_York:20241113T180000
DTSTAMP:20260403T134052
CREATED:20241002T191210Z
LAST-MODIFIED:20241121T191525Z
UID:10042-1731517200-1731520800@glaucomafoundation.org
SUMMARY:Webinar - Interventional Glaucoma - What Does It Mean For Patients?
DESCRIPTION:In “interventional glaucoma\,” glaucoma is treated with minimally invasive surgeries or interventional procedures much earlier in the disease process. It is a shift away from the way glaucoma was treated years ago\, which typically began with eyedrops and only progressed to surgery at the middle or end of the disease progression. Interventional glaucoma intervenes earlier in the treatment process. \nNathan M. Radcliffe\, M.D. is a highly-experienced glaucoma and cataract surgeon. He was the Director of the Glaucoma Services at Cornell\, and then NYU and Bellevue Hospital\, and currently is Associate Clinical Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai. Dr. Radcliffe is unique because he is active in both academic and private practice settings. He is a microincisional glaucoma surgery (MIGS) innovator and instructor and is the Chief Editor of the publication Glaucoma Physician. \nDr. Radcliffe was the first surgeon in New York to offer patients the CyPass Supraciliary Microstent\, the Kahook Dual Blade Goniotomy\, Visco 360 and Trab 360\, the G6 micropulse laser\, and Allergan’s Xen subconjunctival implant. \nDr. Radcliffe has managed some of the most difficult glaucoma and cataract cases from all over the world and is truly able to offer a tailored glaucoma and cataract surgery to his patients\, being able to perform all of the available glaucoma surgeries that are currently FDA approved\, and knowing the procedures and the efficacy and safety data well enough to correlate the optimal procedure with the patient’s disease.
URL:https://glaucomafoundation.org/event/webinar-interventional-glaucoma-what-does-it-mean-for-patients/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/Radcliffe-webinar-Insta-e1727896724169.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240912
DTEND;VALUE=DATE:20240913
DTSTAMP:20260403T134052
CREATED:20240913T162618Z
LAST-MODIFIED:20240913T173425Z
UID:9989-1726099200-1726185599@glaucomafoundation.org
SUMMARY:Webinar - The Role of Genetics in Glaucoma Diagnosis & Prevention
DESCRIPTION:Janey L. Wiggs\, M.D.\, Ph.D. is a physician-scientist at the Massachusetts Eye and Ear Infirmary and Harvard Medical School. She is currently the Paul Austin Chandler Professor of Ophthalmology at Harvard Medical School and is the Vice Chair for Clinical Research in Ophthalmology at the Massachusetts Eye and Ear Infirmary. She also directs the CLIA-certified genetic testing laboratory at the Massachusetts Eye and Ear Infirmary and is a co-director of the Ocular Genomics Institute. \nDr. Wiggs received her B.A. and Ph.D. degrees in biochemistry from the University of California at Berkeley and her M.D. degree from Harvard Medical School. She did post-doctoral training in molecular genetics of retinoblastoma under the direction of Dr. Ted Dryja. Dr. Wiggs completed the ophthalmology residency at the Massachusetts Eye and Ear Infirmary and received fellowship training in glaucoma and also in medical genetics and is one of only a few ophthalmologists certified by both the American Board of Ophthalmology and the American Board of Medical Genetics. \nDr. Wiggs was the inaugural chair of the Genetics Group for ARVO and is an ARVO gold fellow.  She currently serves on the editorial boards of IOVS\, JAMA Ophthalmology\, Molecular Vision\, Journal of Glaucoma\, and Annual Reviews in Vision Science. She is a member of the scientific advisory boards for the Glaucoma Research Foundation\, the Glaucoma Foundation\, and Research to Prevent Blindness and is a past member of the National Advisory Council of the National Eye Institute.  She has received the Heed Award\, the Heed/Knapp Award\, the Research to Prevent Blindness Scholar Award\, the AAO Honor Award\, the Lew Wasserman Merit Award\, the Alcon Research Award\, the David L. Epstein award (ARVO)\, Mildred Weisenfeld award (ARVO)\, the Heed-Gutman award and was a winner of the NEI Audacious Goal competition. She has delivered numerous named lectures including the Clinician-Scientist Award lecture (American Glaucoma Society) and the Shaffer Lecture (American Academy of Ophthalmology). She is a member of the Glaucoma Research Society\, the American Ophthalmological Society\, the Academia Ophthalmologica Internationalis a former member of NEI scientific advisory council\, and an elected member of the National Academy of Medicine. \nDr. Wiggs has published 213 original peer-reviewed research investigations as well as 75 reviews\, editorials\, and book chapters.  Her publications have been in top journals including New England Journal of Medicine\, Nature Genetics\, Nature Communications\, American Journal of Human Genetics\, Cell\, Proceedings of the National Academy of Science\, PLoS Genetics\, Human Molecular Genetics and Genetics in Medicine as well as top-tier Ophthalmology journals including Ophthalmology\, JAMA Ophthalmology\, American Journal of Ophthalmology and IOVS. \nDr. Wiggs is a pioneer and international leader in ocular genetics. Her research program is focused on the discovery and characterization of genetic factors that contribute to the blinding eye disease glaucoma and has been continuously funded by the National Eye Institute (NEI) for over 30 years. She is the PI of the NEIGHBORHOOD consortium for Primary open-angle glaucoma genetics and a founding member of the International Glaucoma Genetics Consortium.  She has also participated in research programs funded by the US-INDO joint working group (NEI) and the NEI eyeGENE consortium and is currently the Ocular Domain co-chair for the NIH-funded ClinGen project. \nDr. Wiggs has discovered many novel genes associated with common forms of glaucoma with complex inheritance.  She has led large primary open-angle glaucoma genome-wide association studies and has had critical roles in GWAS studies identifying novel loci for intraocular pressure and for exfoliation glaucoma. She has also directed the only normal tension glaucoma GWAS that identified genomic regions associated with disease risk. She also studies the genetic etiologies of familial types of glaucoma and has recently identified EFEMP1 and THBS1 as causal genes for childhood forms of glaucoma. Ongoing research studies include: a multi-ethnic normal tension glaucoma GWAS; a metabolomics study of blood plasma in exfoliation glaucoma patients and controls; whole genome sequencing of families affected by early-onset forms of glaucoma\, investigations related to contributions of rare variants to primary open-angle glaucoma and evaluation of polygenic risk burden in at-risk populations. \nAn overarching goal of Dr. Wiggs’s research is to use disease-related genes to develop gene-based testing and therapeutics.  Using the retinoblastoma gene\, she developed one of the first genetic tests for human disease and the first genetic test for an eye disease.  This test allowed for the timely identification of carriers of retinoblastoma mutations who would benefit from presymtomatic surveillance. Subsequently\, together with Eric Pierce\, she developed a next-generation-based sequencing test for over 300 ocular disease genes including all the genes known to cause glaucoma. She is currently using data from genome-wide association studies to develop glaucoma tests for early detection of primary open-angle glaucoma based on polygenic risk scores.
URL:https://glaucomafoundation.org/event/webinar-the-role-of-genetics-in-glaucoma-diagnosis-prevention/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/poster-Wiggs-Youtube-e1726248852646.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240828T170000
DTEND;TZID=America/New_York:20240828T180000
DTSTAMP:20260403T134052
CREATED:20240729T190134Z
LAST-MODIFIED:20241114T171030Z
UID:9669-1724864400-1724868000@glaucomafoundation.org
SUMMARY:Webinar - Building Connections: Research Progress in Vision-Restoring Therapy for Glaucoma
DESCRIPTION:  \n\n\n\n\nThe Johnson Laboratory at the Johns Hopkins Wilmer Eye Institute has spent the past 5 years working to develop stem cell therapies capable of regenerating the optic nerve and restoring vision for patients suffering from glaucoma. \nThis is a challenging goal since it requires the replacement of lost nerve cells in the eye and the building of new connections between these stem cell-derived neurons and the patient’s own cells in the retina and the brain. \nFollowing up on last year’s TGF webinar\, Dr. Johnson will present new and exciting developments from his research\, showing that human neurons are able to form new connections with the recipient retina after being transplanted into the eye. This advance represents a major step forward towards eventually developing new treatments for reversing blindness in patients with glaucoma.
URL:https://glaucomafoundation.org/event/building-connections-research-progress-in-vision-restoring-therapy-for-glaucoma/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/07/Webinar-August-Johnson-2-BL.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240608T070000
DTEND;TZID=America/New_York:20240608T170000
DTSTAMP:20260403T134052
CREATED:20240729T192329Z
LAST-MODIFIED:20241002T235426Z
UID:9671-1717830000-1717866000@glaucomafoundation.org
SUMMARY:TGF Glaucoma Symposium 2024 Glaucoma – What I Do
DESCRIPTION: \n 
URL:https://glaucomafoundation.org/event/tgf-glaucoma-symposium-2024-glaucoma-what-i-do/
ATTACH;FMTTYPE=image/png:https://glaucomafoundation.org/wp-content/uploads/2024/07/no-credit-1024x1024-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240523
DTEND;VALUE=DATE:20240524
DTSTAMP:20260403T134052
CREATED:20240920T190947Z
LAST-MODIFIED:20240924T215520Z
UID:10012-1716422400-1716508799@glaucomafoundation.org
SUMMARY:Webinar - Restoring Vision: Making Whole Eye Transplantation a Reality
DESCRIPTION:Dr. Calvin Roberts discusses the ARPA-H program\, THEA\, Transplantation of Human Eye Allografts. This national program aims to bring together the expertise of vision scientists from multiple universities and laboratories to restore vision to those who are blind\, by transplanting a donor eye. \nRecent advances in regenerative medicine and biomaterials may allow the functional reconnection of nerves and blood vessels to make this centuries-old dream a reality.
URL:https://glaucomafoundation.org/event/restoring-vision-making-whole-eye-transplantation-a-realit/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/restoring-vision-making-whole-ey-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240515
DTEND;VALUE=DATE:20240516
DTSTAMP:20260403T134052
CREATED:20240920T191128Z
LAST-MODIFIED:20240924T215621Z
UID:10014-1715731200-1715817599@glaucomafoundation.org
SUMMARY:TGF's 40th Anniversary Gala
DESCRIPTION:We would like to say thank you to everyone that supported our 40th Anniversary Gala. Your generous contributions helped us raise $561\,000 and we are truly grateful. Enjoy the recap video and pictures from the event below. You can also click here to see more videos from the event on our YouTube channel.\n\n  \n\n\n\n\n\n\n\n\n\n\n\n  \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nClick for More Photos
URL:https://glaucomafoundation.org/event/tgfs-40th-anniversary-gala/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/tgfs-40th-anniversary-gala-recap.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240424
DTEND;VALUE=DATE:20240425
DTSTAMP:20260403T134052
CREATED:20240920T195844Z
LAST-MODIFIED:20241114T171503Z
UID:10016-1713916800-1714003199@glaucomafoundation.org
SUMMARY:Webinar - Light at the End of Tunnel Vision: The Latest Directions in Glaucoma Care
DESCRIPTION:Therapies for Glaucoma are safer\, more effective\, and more tailored to the patient’s needs than ever before. In this webinar we discussed updates in Surgical Technologies\, Drugs and New Drug Delivery\, New Lasers\, and what is just around the corner. Together let’s shed light on glaucoma therapies to help stop tunnel vision.
URL:https://glaucomafoundation.org/event/light-at-the-end-of-tunnel-vision-the-latest-directions-in-glaucoma-care/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/light-at-the-end-of-tunnel-visio-3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240328
DTEND;VALUE=DATE:20240329
DTSTAMP:20260403T134052
CREATED:20241002T190809Z
LAST-MODIFIED:20241114T171557Z
UID:10045-1711584000-1711670399@glaucomafoundation.org
SUMMARY:Webinar - The Value of a Fellowship
DESCRIPTION:The Glaucoma Foundation provides annual supplemental fellowship grants to women and minority physicians to support their research and professional development. In this fireside chat\, TGF president and CEO Elena Sturman talks to 2022 fellowship recipient Dr. Jose Quiroz and his mentor Dr. Avnish Deobhakta about why awards like this are so valuable.
URL:https://glaucomafoundation.org/event/the-value-of-a-fellowship/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/the-value-of-a-fellowship.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240129
DTEND;VALUE=DATE:20240130
DTSTAMP:20260403T134052
CREATED:20241002T190949Z
LAST-MODIFIED:20241114T172755Z
UID:10047-1706486400-1706572799@glaucomafoundation.org
SUMMARY:TGF Featured on Health Uncensored with Dr. Drew
DESCRIPTION:On Sunday\, January 28th The Glaucoma Foundation was featured on the debut episode of media personality Dr. Drew Pinksy’s show titled “Health Uncensored with Dr. Drew.” TGF President and CEO Elena Sturman was interviewed by Dr. Drew and TGF grant recipient Thomas V. Johnson III\, MD\, PhD from Johns Hopkins spoke about his exciting research.
URL:https://glaucomafoundation.org/event/tgf-featured-on-health-uncensored-with-dr-drew/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/tgf-segment-on-health-uncensored-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240120
DTEND;VALUE=DATE:20240121
DTSTAMP:20260403T134052
CREATED:20230120T192745Z
LAST-MODIFIED:20241114T172249Z
UID:10069-1705708800-1705795199@glaucomafoundation.org
SUMMARY:Webinar - Start With The Young: A Glaucoma Education Pilot Program
DESCRIPTION:This initiative to raise awareness\, starting with young\, is a virtual program presented by Dr. Jose Quiroz\, one of the three most recent recipients of the TGF (Sponsored by Patricia Hill)-RBP Fellowship in Glaucoma and Research Fellow at New York Eye and Ear- Mount Sinai. We are grateful to Ms. Hill for her sponsorship\, Dr. Quiroz for his advocacy and expertise\, and the STEM Institute at CCNY for helping us reach several hundred middle and high school students and their parents representing communities (northern Harlem\, Washington Heights\, and Inwood) with high African American and Hispanic heritage – communities at high risk for glaucoma.
URL:https://glaucomafoundation.org/event/start-with-the-young-a-glaucoma-education-pilot-program/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/start-with-the-young-a-glaucoma-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240111
DTEND;VALUE=DATE:20240112
DTSTAMP:20260403T134052
CREATED:20241002T191210Z
LAST-MODIFIED:20241121T161957Z
UID:10049-1704931200-1705017599@glaucomafoundation.org
SUMMARY:Webinar - I've Been Diagnosed With Glaucoma. Now What?
DESCRIPTION:Please enjoy this insightful webinar titled ‘I’ve Been Diagnosed with Glaucoma. Now What?’ This program is tailored to guide individuals navigating a glaucoma diagnosis\, offering a comprehensive discussion on pivotal topics. From unveiling the hallmarks of good glaucoma care and effective doctor-patient collaboration strategies to actionable steps for managing vision loss\, attendees will gain valuable insights. Learn about the essential questions to ask your doctor\, discover impactful lifestyle adjustments\, and explore the critical need for emotional and psychological support in this empowering session. \n  \n\n\n\nDr. Constance Okeke\, MD\, MSCE\, is a renowned cataract surgeon and a pioneer in micro-invasive glaucoma surgery (MIGS) with Ivy-League training. Dr. Okeke serves as the Lead Glaucoma Specialist at Virginia Eye Consultants\, an Assistant Professor of Ophthalmology at Eastern Virginia Medical School\, and actively contributes to clinical research\, peer-to-peer education\, and publications in esteemed ophthalmology journals. Her dedication to patient education is evident through her AGE Initiative\, Advocates for Glaucoma Education\, where the foundational resource is her most recent book\, “The Glaucoma Guidebook” – A Johns Hopkins Health Book\, which won the Best Book Award from the  American Book Fest. Her accomplishments have earned her recognition on The Ophthalmologist’s Global Power List for 2021 and 2022.
URL:https://glaucomafoundation.org/event/ive-been-diagnosed-with-glaucoma-now-what/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/ive-been-diagnosed-with-glaucoma.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230918
DTEND;VALUE=DATE:20230919
DTSTAMP:20260403T134052
CREATED:20241002T191414Z
LAST-MODIFIED:20241121T162222Z
UID:10052-1694995200-1695081599@glaucomafoundation.org
SUMMARY:Webinar - Insights into Glaucoma and Women's Health: Exploring the Impact of Menopause and Visual Function
DESCRIPTION:Glaucoma is the leading cause of irreversible blindness worldwide. 59% of glaucoma patients are female; therefore\, it is worthwhile to understand if there are associations between female reproductive factors and glaucoma. Dr. Andrew Feola’s group focuses on understanding how menopause and estrogen play a role in risk factors related to the onset of glaucoma and visual function. \nIn this webinar\, he discusses his ongoing preclinical work of glaucoma and menopause and explore the clinical association between the onset of menopause and glaucoma.
URL:https://glaucomafoundation.org/event/insights-into-glaucoma-and-womens-health-exploring-the-impact-of-menopause-and-visual-function/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/insights-into-glaucoma-and-women.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230627
DTEND;VALUE=DATE:20230628
DTSTAMP:20260403T134052
CREATED:20241002T192144Z
LAST-MODIFIED:20241121T162320Z
UID:10055-1687824000-1687910399@glaucomafoundation.org
SUMMARY:TGF's 28th Annual Scientific Think Tank
DESCRIPTION:The Glaucoma Foundation Annual Think Tank convenes experts\, from diverse fields\, and from across the country and around the world\, to share their insights and chart the course for future research that will lead to better treatments on our way to a cure.
URL:https://glaucomafoundation.org/event/tgfs-28th-annual-scientific-think-tank/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/session-6-the-patients-forum-the.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230620T170000
DTEND;TZID=America/New_York:20230620T180000
DTSTAMP:20260403T134052
CREATED:20241002T192339Z
LAST-MODIFIED:20241121T162404Z
UID:10061-1687280400-1687284000@glaucomafoundation.org
SUMMARY:Webinar - How to Save the Sight of Patients with Glaucoma While Minimizing Adverse Reaction from Eye Drops
DESCRIPTION:For patients with glaucoma\, the fact that their disease can be slowed down with pressure-lowering eye drops is unquestionably a good thing. But is there enough focus on the unwanted side effects that come with the daily application of one or more eye drops? \nThis presentation will focus on the ocular surface discomfort that far too many glaucoma patients suffer from. In addition\, examples will be given of ways in which ophthalmologists can stratify the treatments to minimize the individual patient’s adverse effects. All to improve both adherence and quality of life in the growing glaucoma population.
URL:https://glaucomafoundation.org/event/how-to-save-the-sight-of-patients-with-glaucoma-while-minimizing-adverse-reaction-from-eye-drops/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/how-to-save-the-sight-of-patient.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230404T170000
DTEND;TZID=America/New_York:20230404T180000
DTSTAMP:20260403T134052
CREATED:20241002T192453Z
LAST-MODIFIED:20241121T162443Z
UID:10063-1680627600-1680631200@glaucomafoundation.org
SUMMARY:Webinar - The Body-Eye Relationship
DESCRIPTION:Nearly half of American adults have high blood pressure. The interaction between various blood pressure parameters and glaucoma has been the subject of intense investigation for decades. \nHow is systemic blood pressure related to glaucoma?\nWhat effect do blood pressure medications have on blood flow and intraocular pressure?\nAnd how do artificial intelligence and mathematical models help in this research? \nIn this webinar\, Prof. Alon Harris speaks about the body-eye relationship\, focusing on glaucoma\, technology\, and math.
URL:https://glaucomafoundation.org/event/the-body-eye-relationship/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/the-body-eye-relationship.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230307
DTEND;VALUE=DATE:20230308
DTSTAMP:20260403T134052
CREATED:20241002T192559Z
LAST-MODIFIED:20241121T162506Z
UID:10065-1678147200-1678233599@glaucomafoundation.org
SUMMARY:Webinar - Future Prospects for Restoring Vision in Patients with Glaucoma: The Promise of Optic Nerve Regeneration
DESCRIPTION:Regenerative medicine holds tremendous potential for restoring vision loss in glaucoma. What are the obstacles and how far are we from clinical trials?  In this webinar\,  Dr. Johnson will discuss the current state-of-the-art relating to optic nerve regeneration\, and the hurdles we face in actually restoring vision for patients suffering from glaucoma. We will also learn about an exciting international collaboration\, currently underway\, that aims to accelerate the clinical translation of this exciting prospect.\n\nDr. Thomas V. Johnson is a clinician-scientist and the Allan and Shelly Holt Rising Professor of Ophthalmology at the Wilmer Eye Institute at Johns Hopkins. He completed his PhD in neuroscience at the University of Cambridge (UK) where his doctoral research involved directing a collaborative project between a stem cell laboratory at Cambridge and a molecular biology laboratory in the National Eye Institute’s NIH intramural research program\, studying mesenchymal stem cell transplantation as a potential neuroprotective treatment for glaucoma. He has been at Johns Hopkins since 2010 where he completed medical school\, ophthalmology residency\, and glaucoma fellowship\, and served as the Wilmer Eye Institute’s Assistant Chief of Service (ACS).Dr. Johnson is a glaucoma specialist and treats patients in the clinic and OR for 1-2 days per week. The remainder of his time is spent in his translational neuroscience laboratory where is he investigating retinal ganglion cell replacement therapies for vision restoration in glaucoma and other optic neuropathies. He also has a clinical interest in understanding the relationship between intraocular pressure and glaucoma progression\, especially through remote and 24-hour tonometry.
URL:https://glaucomafoundation.org/event/future-prospects-for-restoring-vision-in-patients-with-glaucoma-the-promise-of-optic-nerve-regeneration/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/prospects-for-restoring-vision-i.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230104
DTEND;VALUE=DATE:20230105
DTSTAMP:20260403T134052
CREATED:20241002T192918Z
LAST-MODIFIED:20241121T162547Z
UID:10072-1672790400-1672876799@glaucomafoundation.org
SUMMARY:Webinar - Glaucoma & Your Lifestyle - Health\, Habits\, Happiness
DESCRIPTION:Glaucoma patients often wonder what more they can do for their glaucoma and optic nerve health in addition to the treatments prescribed by their eye-care providers. In this webinar\, Dr. Aakriti Shukla discusses and debunks a variety of lifestyle recommendations for glaucoma. \nAakriti Shukla\, MD is the Leonard A. Lauder Assistant Professor of Ophthalmology at Columbia University Irving Medical Center in NY\, NY. Her research interests include structure-function relationships in glaucoma\, optimization of surgical outcomes\, and sustainability in ophthalmology.
URL:https://glaucomafoundation.org/event/glaucoma-your-lifestyle-health-habits-happiness/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/glaucoma-your-lifestyle-health-h.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221115
DTEND;VALUE=DATE:20221116
DTSTAMP:20260403T134052
CREATED:20241002T193155Z
LAST-MODIFIED:20241121T162630Z
UID:10074-1668470400-1668556799@glaucomafoundation.org
SUMMARY:Webinar - Low-Vision Devices for Everyday Life
DESCRIPTION:Steven Schoenbart\, OD addresses the various ways to educate and assist patients who suffer from vision loss\, including the use of telescopic glasses for “hands free” magnification.
URL:https://glaucomafoundation.org/event/low-vision-devices-for-everyday-life/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/low-vision-devices-for-everyday-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221026
DTSTAMP:20260403T134052
CREATED:20241002T193405Z
LAST-MODIFIED:20241121T162719Z
UID:10078-1666656000-1666742399@glaucomafoundation.org
SUMMARY:Webinar - Remote IOP Monitoring: Lessons Learned from a Doctor and a Patient
DESCRIPTION:Dr. Barbara Wirostko FARVO and glaucoma patient Rebecca Vilender talk about the benefits of measuring your IOP at home\, and how you can access an affordable home-monitoring device. \nGlaucoma is a chronic disease that requires chronic monitoring. IOP monitoring is most often based on measurements taken during clinic visits\, necessarily occurring at a specific day and time during business hours\, often months apart. However\, IOP can vary throughout the day and night; spot measurements cannot capture its fluctuations. \nKnowing this\, many physicians want to monitor IOP at various times. The iCare Home offers a tonometer (an instrument for measuring pressure) that can be easily used by patients outside of their doctor’s office hours. Physicians report that\, for some patients\, the iCare Home tonometer has detected dramatic and potentially dangerous spikes in IOP that they did not capture during office visits. Detecting these IOP spikes\, prior to progression\, may enable earlier intervention\, more accurate treatment\, and better outcomes. \nNow\, you can rent or buy an affordable iCare Home tonometer with a prescription from your physician. Dr. Barbara Wirostko\, founder of MyEyes\, will talk about the process\, and a patient who has used the iCare Home will demonstrate its use and tell us how she benefitted from monitoring her IOP throught the day.
URL:https://glaucomafoundation.org/event/remote-iop-monitoring-lessons-learned-from-a-doctor-and-a-patient/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/remote-iop-monitoring-lessons-le.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221026
DTSTAMP:20260403T134052
CREATED:20241002T193248Z
LAST-MODIFIED:20241121T162754Z
UID:10076-1666656000-1666742399@glaucomafoundation.org
SUMMARY:The Future is Now: Translating New Information into Clinical Practice
DESCRIPTION:This symposium held at the Harvard Club in NYC\, provided a unique opportunity for ophthalmologists and optometrists to explore together the future of diagnosis and treatment.
URL:https://glaucomafoundation.org/event/the-future-is-now-translating-new-information-into-clinical-practice/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/the-future-is-now-translating-ne.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220722
DTEND;VALUE=DATE:20220723
DTSTAMP:20260403T134052
CREATED:20241002T193459Z
LAST-MODIFIED:20241121T161900Z
UID:10080-1658448000-1658534399@glaucomafoundation.org
SUMMARY:Webinar - Navigating the Psycho/Social Aspects of Glaucoma
DESCRIPTION:The psycho-social issues of glaucoma that so dramatically affect a patient’s quality of life are rarely addressed in glaucoma care as they have been in other medical situations such as AIDS\, cancers and Alzheimers.How can glaucoma affect your professional and personal life? How does stress impact glaucoma? What techniques can reduce anxiety? What should you look for in a therapist? Glaucoma patient Joe Lovett and psychologist Deborah Waxenberg explore these and other questions about living with glaucoma.
URL:https://glaucomafoundation.org/event/navigating-the-psycho-social-aspects-of-glaucoma/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/navigating-the-psycho-social-asp.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220709
DTEND;VALUE=DATE:20220710
DTSTAMP:20260403T134052
CREATED:20241002T193710Z
LAST-MODIFIED:20241121T161841Z
UID:10081-1657324800-1657411199@glaucomafoundation.org
SUMMARY:Webinar - Harnessing Artificial Intelligence to Improve Glaucoma Management: Challenges & Opportunities
DESCRIPTION:“Harnessing Artificial Intelligence to Improve Glaucoma Management: Challenges & Opportunities”\n\n\n\n\n\n\n\nHow will artificial intelligence improve glaucoma care? \nHow can AI support clinicians in the treatment of their glaucoma patients? \nWhat are the challenges in implementing appropriate AI systems in clinical practice? \nThis webinar will provide basic information about artificial intelligence (AI) in ophthalmology\, and an overview of the latest developments in the use of AI to automate and improve the management of glaucoma. \nDr. Zangwill’s presentation will highlight the opportunities for providing real-time AI decision support to clinicians treating glaucoma patients\, as well as the challenges in implementing appropriate AI systems in clinical practice. \nLinda Zangwill\, Ph.D.\, Professor of Ophthalmology at the University of California San Diego serves as Director of Clinical Research of the Hamilton Glaucoma Center\, and Director of the Imaging Data Evaluation and Analysis Reading Center.  Dr. Zangwill has published over 350 manuscripts in peer-reviewed journals. She is an elected executive committee member of the Glaucoma Research Society and is an Association for Research in Vision and Ophthalmology Gold Fellow. \nDr. Zangwill has been continuously funded by the National Eye Institute for 25 years as Principal Investigator for the Diagnostic Innovations in Glaucoma Study (DIGS) and more recently\, the African Descent and Glaucoma Evaluation Study (ADAGES).  Dr. Zangwill’s clinical research focuses on improving our understanding of the complex relationship between structural and functional change over time in the aging and glaucoma eye\, developing computational and machine learning techniques to improve glaucoma detection\, developing methods to differentiate between highly myopic eyes with and without glaucoma\, and identifying risk factors that can predict rapidly progressing glaucoma.
URL:https://glaucomafoundation.org/event/harnessing-artificial-intelligence-to-improve-glaucoma-management-challenges-opportunities/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/08/how-will-artificial-intelligence-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220416
DTEND;VALUE=DATE:20220417
DTSTAMP:20260403T134052
CREATED:20241002T193925Z
LAST-MODIFIED:20241121T162831Z
UID:10085-1650067200-1650153599@glaucomafoundation.org
SUMMARY:Webinar - Using Artificial Intelligence to Disentangle Glaucoma Pathogenesis
DESCRIPTION:This video is from our March 15th Zoom where Dr. Louis Pasquale discussed how artificial intelligence will impact glaucoma prevention and treatment. \nPrimary open-angle glaucoma (POAG) is a disease subtype defined by chronic\, progressive\, and irreversible retinal ganglion cell (RGC) loss without clinically evident causes for either elevated intraocular pressure (IOP) or optic nerve degeneration. Globally\, there are currently 53 million POAG cases\, with projections of 80 million cases by 2040. These staggering statistics are a clarion call to find cost-effective strategies for glaucoma prevention and treatment. This talk will provide an overview regarding our approach to leverage artificial intelligence in large cohorts containing a wealth of biomarker and environment data to meet these challenges and reduce ocular morbidity due to glaucoma. \nLouis R. Pasquale\, MD is is the Shelley and Steven Einhorn Distinguished Professor of Ophthalmology and Site Chair of the Department of Ophthalmology at Mount Sinai Hospital. He is Vice Chair of Translational Ophthalmology Research at Mount Sinai Healthcare System. \nDr. Pasquale is a member of the PLOS One\, Journal of Glaucoma\, Ophthalmology Glaucoma\, Asia-Pacific Journal of Ophthalmology\, and American Journal of Ophthalmology editorial boards. He currently serves as Glaucoma Trustee for ARVO and is a member of the National Institute of Health’s National Advisory Eye Council. \nAn NIH Principal Investigator with continuous support since 2006\, his research leverages the rich resources available in the Nurses Health Study\, Health Professional Follow-up Study and the Women’s Genome Health Study\, and focuses on the discovery of primary prevention strategies in the open-angle glaucomas. \nPhysicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical\, device and biotechnology companies to improve patient care\, develop new therapies\, and achieve scientific breakthroughs.
URL:https://glaucomafoundation.org/event/using-artificial-intelligence-to-disentangle-glaucoma-pathogenesis/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/08/using-artificial-intelligence-to-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220404
DTEND;VALUE=DATE:20220405
DTSTAMP:20260403T134052
CREATED:20241002T193823Z
LAST-MODIFIED:20241121T162838Z
UID:10083-1649030400-1649116799@glaucomafoundation.org
SUMMARY:Webinar - Glaucoma: Seeing the Light at the End of the (Nano)Tunnel"
DESCRIPTION:At the lab of Dr. Adriana Di Polo at University of Montreal\, researchers are paving the way for the development of therapeutic approaches to protect pericytes and their nanotubes. The goal?  Restoring vascular health and vision in glaucoma. \nIn living animals\, as in humans\, the retina uses the oxygen and nutrients contained in the blood to function properly. This vital exchange takes place through capillaries\, the thinnest blood vessels in all organs of the body. Pericytes are small cells that wrap around capillaries. A pericyte can control the amount of blood passing through a single capillary simply by squeezing and releasing it. \nIn this webinar from April 4\, Dr. Di Polo presented new findings from her laboratory demonstrating the critical role that pericytes play in vascular dysfunction in glaucoma. A key discovery is that inter-pericyte tunnelling nanotubes\, thin nanotubes by which pericytes communicate with each other\, are damaged in glaucomatous eyes contributing to the death of retinal neurons. Strategies that restore calcium equilibrium in pericytes are effective to rescue vascular function and promote neuroprotection. This work paves the way for the development of therapeutic approaches to protect pericytes and their nanotubes with the goal of restoring vascular health and vision in glaucoma.
URL:https://glaucomafoundation.org/event/glaucoma-seeing-the-light-at-the-end-of-the-nanotunnel/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/glaucoma-seeing-the-light-at-the.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220222
DTEND;VALUE=DATE:20220223
DTSTAMP:20260403T134052
CREATED:20241002T192658Z
LAST-MODIFIED:20241121T162915Z
UID:10067-1645488000-1645574399@glaucomafoundation.org
SUMMARY:Webinar - What do cold hands have to do with glaucoma?
DESCRIPTION:Learn about Flammer’s Syndrome with Josef Flammer\, MD and patient Hillary Golden \nIn 2020\, Hillary Golden went to see an optometrist to treat a stye. She was completely surprised when the doctor was more concerned about her optic nerve. She was diagnosed with normal tension glaucoma (NTG). Hillary had lost a good amount of visual field already and was immediately referred to a glaucoma specialist.  While researching NTG\, she kept coming across something called Flammer Syndrome. She fit the patient profile\, so she read study after study to learn more.  This led her to reach out to Dr. Josef Flammer\, whom the syndrome was monikered after\, to gather more information.  She sent an email\, not expecting a reply\, and was delighted when she heard back from Dr. Flammer himself. \nHillary speaks publicly about her diagnosis\, how glaucoma affects patients in everyday life\, and how she manages her disease. Her career has included sales and training of medical devices\, imaging equipment\, and computer guided surgical navigation. She is currently a clinical consultant in the glaucoma space. \nDr. Josef Flammer is a Swiss ophthalmologist with a specialty in glaucoma. He is an emeritus director of the Eye Clinic at Basel University Hospital. Dr. Flammer was one of the first researchers to demonstrate systemic side effects of locally administered beta-blockers (i.e. eye drops) in ophthalmology. He and his collaborators found that intraocular pressure variation is as important for the development of glaucoma as a constantly elevated intraocular pressure – long considered the main\, if not the only\, cause of glaucoma. In numerous research projects\, he demonstrated that glaucoma could be caused by a dysregulation of ocular blood flow\, even at normal levels of intraocular pressure. Flammer discovered that vasospasms in the eye are a manifestation of a general vasospastic syndrome. Later\, he noted that such spasms are only the tip of the iceberg and an indication of a much more generalized vascular dysregulation in the human body\, increasing the risk of eye disease\, particularly of normal tension glaucoma. Dr. Flammer noted that people with primary vascular dysregulation have other symptoms and signs\, leading to the establishment of the term Flammer Syndrome. Among many other discoveries\, he also demonstrated the relationship between eye disease and heart disease.At the Basel Eye Clinic\, Dr. Flammer initiated one of the most renowned annual conferences for ophthalmologists in Europe\, the Basel Ophthalmo Meeting. In addition to hundreds of original papers\, he is the author of  “Glaucoma\,” a book intended for the general public which has so far been published in 22 languages. It is considered the world’s most widely used non-fiction book on this ocular disease.
URL:https://glaucomafoundation.org/event/what-do-cold-hands-have-to-do-with-glaucoma/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/what-do-cold-hands-have-to-do-wi.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211111T170000
DTEND;TZID=America/New_York:20211111T180000
DTSTAMP:20260403T134052
CREATED:20241002T194030Z
LAST-MODIFIED:20241121T163023Z
UID:10086-1636650000-1636653600@glaucomafoundation.org
SUMMARY:Webinar - NEW HORIZONS IN GLAUCOMA TREATMENT
DESCRIPTION:Dr. Jeffrey Liebmann joined us on Zoom to talk about the latest news in glaucoma procedures and treatments and answer viewer questions. This webinar was sponsored by Santen Pharmaceuticals. \n\n\n\n\n\n\n\n\n\nDr. Jeffrey M. Liebmann graduated from Boston University School of Medicine\, completed his ophthalmology residency at the State University of New York/Downstate Medical Center\, and his glaucoma fellowship at the New York Eye and Ear Infirmary. Dr. Liebmann serves as Shirlee and Bernard Brown Professor\, Vice-Chair\, and Director of the Glaucoma Division of the Department Ophthalmology at Columbia University Medical Center. He is a fellow of the American Academy of Ophthalmology\, Association for Research in Vision and Ophthalmology and American College of Surgeons. Dr. Liebmann serves as a member of the Board of Governors of the World Glaucoma Association\, Board of Directors of The Glaucoma Foundation and Secretary-Treasurer of the New York Glaucoma Society. Dr. Liebmann is a past-President of the World Glaucoma Association\, American Glaucoma Society\, and the New York Society for Clinical Ophthalmology\, Emeritus Editor-in Chief of Journal of Glaucoma and was co-founder of the New York Glaucoma Research Institute\, the American Glaucoma Society Foundation and ASCRS Glaucoma Day. \nIn addition to maintaining a busy tertiary-care referral practice in New York City\, Dr. Liebmann is Principal Investigator for the NIH African Descent and Glaucoma Evaluation Study (ADAGES) and Ocular Hypertension Treatment Study (OHTS III) at Columbia University and is the author and/or co-author of more than 1000 medical and scientific papers\, book chapters\, and abstracts. He has lectured widely in the United States and abroad on glaucoma diagnosis and management. His current main areas of research interest include the causes of glaucoma\, glaucoma progression\, glaucoma surgery\, ocular imaging\, and neuroprotection.
URL:https://glaucomafoundation.org/event/new-horizons-in-glaucoma-treatment/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/new-horizons-in-glaucoma-treatme-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210813
DTEND;VALUE=DATE:20210814
DTSTAMP:20260403T134052
CREATED:20241002T194151Z
LAST-MODIFIED:20241121T163037Z
UID:10087-1628812800-1628899199@glaucomafoundation.org
SUMMARY:A Fireside Chat With Dr. George Spaeth & Mark Lesselroth
DESCRIPTION:The Glaucoma Foundation invites you to a fireside video chat with Mark Lesselroth and Dr. George Spaeth who delve into some of the common misconceptions about glaucoma and how patients can take control of their health. \nWe will be following up on this conversation with a written Q&A in the September issue of our e- newsletter. \nWe hope you find this discussion informative and thought-provoking. If you have a comment or question\, please send it to us by email by August 30. We look forward to hearing from you.
URL:https://glaucomafoundation.org/event/a-fireside-chat-with-dr-george-spaeth-mark-lesselroth/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/fireside-chat.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210527
DTEND;VALUE=DATE:20210528
DTSTAMP:20260403T134052
CREATED:20241002T194253Z
LAST-MODIFIED:20241121T163100Z
UID:10089-1622073600-1622159999@glaucomafoundation.org
SUMMARY:Webinar - Low-Tech : High Tech Low Vision Solutions 101
DESCRIPTION:We had a panel of low-vision specialists and patient advocates talk about a range of techniques and assets you can use to improve your home and work-life. From simple low-tech methods and products to advanced optical and electronic technologies.
URL:https://glaucomafoundation.org/event/low-tech-high-tech-low-vision-solutions-101/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/08/low-tech-high-tech-low-vision-so-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210312
DTEND;VALUE=DATE:20210313
DTSTAMP:20260403T134052
CREATED:20241002T194440Z
LAST-MODIFIED:20241114T171901Z
UID:10092-1615507200-1615593599@glaucomafoundation.org
SUMMARY:Webinar - Update on Home Tonometry: An Easy Way to Track Your IOP
DESCRIPTION:Click the video below to see our webinar about “MyEYES.” MyEYES is dedicated to helping you better manage your glaucoma with access to the personal tonometer\, iCare HOME. \niCare HOME is the most advanced device available for a patient to measure their intra-ocular pressure (IOP) any time of day or night. Whether you suffer from mild or severe glaucoma or are only a glaucoma suspect\, MyEYES can help you learn more about the variability of your IOP in the convenience of your home. Managing IOP is a critical step in avoiding preventable deterioration of your vision and the iCare HOME is the next step in managing your eye health.
URL:https://glaucomafoundation.org/event/update-on-home-tonometry-an-easy-way-to-track-your-iop/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/09/update-on-home-tonometry-an-easy.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210227T170000
DTEND;TZID=America/New_York:20210227T180000
DTSTAMP:20260403T134052
CREATED:20241002T194350Z
LAST-MODIFIED:20241121T163138Z
UID:10090-1614445200-1614448800@glaucomafoundation.org
SUMMARY:Webinar - Bringing the Latest Glaucoma Science Directly to the Patient
DESCRIPTION:TGF held a webinar with four brief\, illuminating talks by experts on gene therapy\, optic nerve regeneration\, the role of artificial intelligence\, and the importance of trust between physician and patient. We also had perspectives from two patients. Presented in two parts with Q&As. The webinar was made possible with support from Santen\, Inc. and New York Community Trust.
URL:https://glaucomafoundation.org/event/bringing-the-latest-glaucoma-science-directly-to-the-patient/
ATTACH;FMTTYPE=image/jpeg:https://glaucomafoundation.org/wp-content/uploads/2024/10/bringing-the-latest-glaucoma-sci.jpg
END:VEVENT
END:VCALENDAR